Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Changes in gut microbiota composition have ...

Abstract Research of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia (FM), two acquired chronic illnesses affecting mainly females, has failed to ascertain their frequent ...

SEOUL — North Korean leader Kim Jong Un vowed that Pyongyang's nuclear program would continue "indefinitely," state media reported on Wednesday, days after United States President Donald Trump said he ...

Federal Opposition Leader Peter Dutton and the Liberal-National Coalition have said that, if they win the next Federal Election, they would attempt to build nuclear reactors in communities around ...

TORONTO — A historic proposal that would see three major tobacco companies pay out billions to provinces and territories as well as former smokers across Canada is set to face its final test over the ...

There were no calamitous new developments last year with respect to nuclear weapons—but this is hardly good news. Longstanding concerns about nuclear weapons—involving the modernization and expansion ...

American nuclear weapons, specifically the atomic bomb, brought World War II to a close. They then averted a hot war with the Soviet Union and bolstered decades of global stability. The decisive ...

Accenture’s federal arm has won the $3.5 billion CIO Business Operation Support Services, or CBOSS, recompete blanket purchase agreement from the Department of Energy to provide IT professional ...

Iran sends conciliatory signals to leaders in Davos Iranian official Zarif tells critics 'let's talk' UN nuclear watchdog says Iran pushing hard on enrichment IAEA chief Grossi says dialogue ...

Your guide to what the 2024 US election means for Washington and the world Stellantis, the carmaker that owns the Fiat and Chrysler brands, is planning to invest more than $5bn in the US in a deal ...

Five years ago, Gilead signed a massive deal with Galapagos. After a restructuring, the pharma is still hunting for the potential it saw at the original signing. Gilead had reached an inflection point ...